Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Wang X, Hong Y, Meng S, Gong W, Ren T, Zhang T, Liu X, Li L, Qiu L, Qian Z, Zhou S, Zhao M, Zhai Q, Meng B, Ren X, Zhang H, Wang X. Wang X, et al. Among authors: meng b, meng s. Clin Immunol. 2022 Oct;243:109105. doi: 10.1016/j.clim.2022.109105. Epub 2022 Aug 31. Clin Immunol. 2022. PMID: 36055572 Free article.
Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
Dong L, Lv H, Li W, Song Z, Li L, Zhou S, Qiu L, Qian Z, Liu X, Feng L, Meng B, Fu K, Wang X, Pan-Hammarström Q, Wang P, Wang X, Zhang H. Dong L, et al. Among authors: meng b. Oncotarget. 2016 May 31;7(22):33350-62. doi: 10.18632/oncotarget.9061. Oncotarget. 2016. PMID: 27147575 Free PMC article.
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL.
Li L, Zhang X, Zhang T, Song Z, Hu G, Li W, Li L, Qiu L, Qian Z, Zhou S, Liu X, Feng L, Pan Y, Zhai Q, Meng B, Ren X, Fu K, Wang P, Wang X, Zhang H. Li L, et al. Among authors: meng b. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e381-e389. doi: 10.1016/j.clml.2018.06.010. Epub 2018 Jun 19. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29983382
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.
Wang X, Zhang T, Song Z, Li L, Zhang X, Liu J, Liu X, Qiu L, Qian Z, Zhou S, Feng L, Hu G, Meng B, Zhai Q, Ren X, Fu K, Li L, Wang P, Zhang H. Wang X, et al. Among authors: meng b. Int J Cancer. 2019 Sep 1;145(5):1414-1422. doi: 10.1002/ijc.32144. Epub 2019 Feb 4. Int J Cancer. 2019. PMID: 30664812 Free article.
Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B-cell lymphoma.
Zhang T, Lu Y, Liu X, Zhao M, He J, Liu X, Li L, Qiu L, Qian Z, Zhou S, Meng B, Zhai Q, Ren X, Zhang H, Wang X. Zhang T, et al. Among authors: meng b. Am J Hematol. 2022 Jan 1;97(1):E14-E17. doi: 10.1002/ajh.26392. Epub 2021 Nov 3. Am J Hematol. 2022. PMID: 34710245 Free article. No abstract available.
897 results